miR-21 and miR-155 promote the development of NSCLC by downregulating SOCS1, SOCS6, and PTEN. miR-21 also promotes metastasis to the brain through the ERK-STAT3 signaling pathway, which inhibits DGKB. This evidence concerns the gene DGKB and non-small cell lung carcinoma.